- Facing pharmacy trends for the remainder of the year
- MedFolio launches electronic pillbox to improve patient adherence
- Kathleen Sebelius cites pharmacists' importance as Rite Aid CEO introduces Obamacare resource program
- Cardinal Health invites independent pharmacy owners to ‘discover new horizons’ at RBC 2013
- Helping independents compete in specialty pharmacy, Cardinal Health launches new suite of services at RBC 2013
SCOTTSDALE, Ariz. — The McKesson Patient Relationship Solutions last week was recognized for its best-in-class adherence solutions by being named a finalist in the 2013 PM360 Trailblazer Awards for the second consecutive year. McKesson was named a finalist for the Best Persistence Campaign for a co-pay card program targeting oncology patients.
The PM360 Trailblazer Awards are given to companies, marketers and brand managers representing top talent and brands. Selected by the PM360 editorial board from more than 800 award applications, finalists represent the most creative and forward-thinking leadership of their fields.
McKesson won the 2012 PM360 Trailblazer Award for the Best Direct Marketing to Patient Campaign for its Lab-Band Behavioral Call Campaign on behalf of Ogilvy Healthworld and Allergan. McKesson’s LEO Quality Care Program was selected as a finalist for the 2012 PM360 Trailblazer Award for the Best Persistence Campaign Award.
“MPRS is honored to be recognized again by PM360 for our ongoing efforts to create and implement innovative solutions on behalf of pharmaceutical and medical device companies that advance patient health," stated Derek Rago, VP and general manager, McKesson Patient Relationship Solutions. "We are extremely proud of this unique program designed to help achieve healthier patient outcomes through increased drug adherence and aid healthcare professionals as they manage critical cancer therapies."
Despite the seriousness of a cancer diagnosis, research has demonstrated adherence levels among cancer patients are as low as 20%, McKesson noted. Working with a large manufacturer, the co-pay card program was designed to ensure patient access to vital therapies and help improve adherence to these therapies.
The goal of the co-pay card program, which covered multiple brands of oral and infused oncology drugs, was to provide flexible resources to help patients through a single, patient-friendly platform. From co-pay savings, to patient education and other support resources, the brands sought to drive usage and meet the needs of their patients by offering participants access to co-pay savings resources — at their doctor’s office, online and through their retail or specialty pharmacy. This solution provided a program that doctors could easily navigate and execute despite highly individualized regimens.
Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.